Pharmaceuticals
Novartis strikes deal with UK biotech for up to US$1.7 billion
Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences
Malaysia’s retail pharmacy boom draws billion-ringgit bets as IPO pipeline builds
The catalyst – news that BIG Caring Group is weighing a blockbuster listing in Bursa Malaysia next year
Chemistry AI startup ChemLex raises US$45 million, sets up global HQ in Singapore
The funds will be used to hire more hardware and software engineers as well as chemists in the city-state
US, UK announce deal on pharmaceutical tariffs, drug pricing
[WASHINGTON] The Trump administration has reached an agreement with the UK to allow tariff-free imports of pharmaceutical products in exchange for a significant reduction in rebates drugmakers pay to ...
What China will dominate next
The country’s high-speed innovation holds lessons for the world
Singapore’s October factory output records highest jump in 15 years, up 29.1% on pharma surge
This surprised private-sector economists who had expected a 6.7% growth
Pharmaceutical chain Big Caring weighs Malaysia IPO next year at up to RM20 billion valuation: sources
It could raise as much as RM6 billion, making it one of Malaysia’s biggest listings in years
J&J to buy Halda Therapeutics in US$3.05 billion cash deal
[NEW YORK] Johnson & Johnson has agreed to buy the cancer treatment biotech Halda Therapeutics for US$3.05 billion cash, part of a strategy to cope with eroding sales for its major psoriasis drug.
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
[BENGALURU] Pfizer on Friday (Oct 31) filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker’s US$8.5 billion bid ...
How I knew when to start backing Novo Nordisk’s biggest rival instead
The Danish firm’s complacency is its undoing in the weight-loss drug war
